Abstract | PURPOSE: To use genetically engineered mouse models (GEMM) and orthotopic syngeneic murine transplants (OST) to develop gene expression-based predictors of response to anticancer drugs in human tumors. These mouse models offer advantages including precise genetics and an intact microenvironment/immune system. EXPERIMENTAL DESIGN: We examined the efficacy of 4 chemotherapeutic or targeted anticancer drugs, alone and in combination, using mouse models representing 3 distinct breast cancer subtypes: Basal-like (C3(1)-T-antigen GEMM), Luminal B (MMTV-Neu GEMM), and Claudin-low (T11/TP53-/- OST). We expression-profiled tumors to develop signatures that corresponded to treatment and response, and then tested their predictive potential using human patient data. RESULTS: CONCLUSIONS: These results show that murine-derived gene signatures can predict response even after accounting for common clinical variables and other predictive genomic signatures, suggesting that mice can be used to identify new biomarkers for human patients with cancer.
|
Authors | Jerry Usary, Wei Zhao, David Darr, Patrick J Roberts, Mei Liu, Lorraine Balletta, Olga Karginova, Jamie Jordan, Austin Combest, Arlene Bridges, Aleix Prat, Maggie C U Cheang, Jason I Herschkowitz, Jeffrey M Rosen, William Zamboni, Norman E Sharpless, Charles M Perou |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 19
Issue 17
Pg. 4889-99
(Sep 01 2013)
ISSN: 1557-3265 [Electronic] United States |
PMID | 23780888
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | ©2013 AACR. |
Chemical References |
- Biomarkers, Pharmacological
- Quinazolines
- Lapatinib
- Doxorubicin
- Cyclophosphamide
- Carboplatin
- Erlotinib Hydrochloride
- Paclitaxel
|
Topics |
- Animals
- Animals, Genetically Modified
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, pharmacology)
- Biomarkers, Pharmacological
(metabolism)
- Breast Neoplasms
(drug therapy, genetics)
- Carboplatin
(administration & dosage)
- Cyclophosphamide
(administration & dosage)
- Doxorubicin
(administration & dosage)
- Erlotinib Hydrochloride
- Female
- Gene Expression Profiling
(methods)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Lapatinib
- Mice
- Oligonucleotide Array Sequence Analysis
- Paclitaxel
(administration & dosage, pharmacokinetics)
- Quinazolines
(administration & dosage)
- Tumor Microenvironment
(drug effects, genetics)
|